Organization
Targeted Therapy Technologies
4 clinical trials
Clinical trial
A Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered From an Episcleral Reservoir for Treatment of Macular Edema Secondary to Diabetes and Other CausesStatus: Active (not recruiting), Estimated PCD: 2024-09-30
Clinical trial
A Phase I Study of Sequestered Transscleral, Controlled-Release Topotecan Delivered From an Episcleral Reservoir in Retinoblastoma EyesStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Clinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-09-30